言語を選択
新規登録

HLA-DRA1*0101 & HLA-DRB1*1101 & CLIP (PVSKMRMATPLLMQA)

HLA-DRA1*0101 & HLA-DRB1*1101 & CLIP (PVSKMRMATPLLMQA) 製品リスト

  • 属性

    Protein (1)

  • 製品ライブラリ

    オンライン (1)

  • 種

    Human (1)

  • タグ

    His Tag & Avi Tag (1)

  • マーカー

    Biotin-labeled (1)

製品番号種発現システム製品説明タンパク質の構造純度特性
HLP-H82Ed
Human
HEK293
Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01&CLIP (PVSKMRMATPLLMQA) Complex Protein (Monomer)
総数量1
  • 1

HLA-DRA1*0101 & HLA-DRB1*1101 & CLIP (PVSKMRMATPLLMQA)バックグランド

HLA-DR is a isotype of MHC Class II responsible for presenting foreign antigens to the immune system's helper T-cells. The CLIP peptide, derived from the invariant chain, occupies the peptide-binding groove of the newly synthesized HLA-DR molecule to prevent it from loading irrelevant peptides inside the cell.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
NapabucasinDP1; DP2A; BB-608; GB-201; BBI-608; BBI-608-DP1; BBI-608-DP2A; Z1HHM49K7O (UNII code)Phase 3 Clinical1globe Biomedical Co Ltd, Pharmaceutics International Inc, Boston Biomedical IncHematologic Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Neoplasms; Glioblastoma; Mesothelioma; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms
詳細
Nanocurcumin (Tehran University of Medical Sciences)Phase 2 ClinicalTehran University Of Medical SciencesNeoplasms; Periapical Diseases
詳細
OPB-111077OPB-111077Phase 2 ClinicalOtsuka Pharmaceutical Co LtdLymphoma, B-Cell; Solid tumours; Neoplasms; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Leukemia, Myeloid, Acute; Carcinoma, Hepatocellular
詳細
DanvatirsenAZD-9150; STAT-3Rx; ISIS-345794; ISIS-481464; ISIS-STAT3Rx; IONIS-STAT3Rx; ISIS-STAT3-2.5Rx; IONIS-STAT3-2.5RxPhase 2 ClinicalIonis Pharmaceuticals IncOvarian Neoplasms; Squamous Cell Carcinoma of Head and Neck; Mismatch Repair Deficient Cancer; Lymphoma, Large B-Cell, Diffuse; Triple Negative Breast Neoplasms; Pancreatic Neoplasms; Ascites; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms
詳細
HL-237HL-237Phase 2 ClinicalHanlim Pharmaceutical Co LtdArthritis, Rheumatoid
詳細
M-1001M-1001; MEDICA-M1001Phase 2 ClinicalSyndromexDyslipidemias
詳細
NT-219NT-219; NT219Phase 2 ClinicalTyrNovo LtdSolid tumours; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colorectal Neoplasms; Neoplasm Metastasis
詳細
Dimethylaminomicheliolide FumarateACT-001Phase 2 ClinicalTianjin Accendatech Technology Co LtdGlioblastoma; Small Cell Lung Carcinoma; Ganglioglioma; Central Nervous System Neoplasms; Optic Neuritis; Neuromyelitis Optica; Breast Neoplasms; Glioma; Brain metastases; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma
詳細
C-188-9C188-9; C-188-9; TTI-101Phase 2 ClinicalBaylor College Of MedicineLiver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Neoplasms; Idiopathic Pulmonary Fibrosis; Pancreatic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Melanoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung
詳細
WP-1066WP-1066Phase 2 ClinicalThe University Of Texas MD Anderson Cancer CenterMedulloblastoma; Glioblastoma; Neoplasms; Brain Neoplasms; Brain metastases; Glioma; Melanoma
詳細
YY-201YY-201; YY201Phase 1 ClinicalShanghai Yuyao Biotechnology Co LtdHematologic Neoplasms; Solid tumours; Prostatic Hyperplasia
詳細
GLG-302GLG-302; GLG-805; S31-201; NSC-74859Phase 1 ClinicalH Lee Moffitt Cancer Center & Research InstituteBreast Neoplasms
詳細
MOL-4239MOL-4239; WP-1220Phase 1 ClinicalThe University Of Texas MD Anderson Cancer CenterPsoriasis; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides
詳細
Amcasertib/NapabucasinPhase 1 ClinicalBoston Biomedical IncNeoplasms
詳細
ST-2286ST-2286; JW2286; JW-2286Phase 1 ClinicalC&C Research LaboratoriesSolid tumours; Stomach Neoplasms; Breast Neoplasms; Colorectal Neoplasms
詳細
KT-333KT-333; I-003Phase 1 ClinicalKymera Therapeutics IncLymphoma, T-Cell, Peripheral; Solid tumours; Leukemia, Lymphoid; Neoplasms; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Cutaneous; Leukemia, Large Granular Lymphocytic
詳細
VVD-130850VVD-130850; BAY-3630914Phase 1 ClinicalSolid tumours
詳細
DCR-STAT3DCR-STAT3Phase 1 ClinicalDicerna Pharmaceuticals IncSolid tumours; Neoplasms
詳細
OPB-171775OPB-171775Phase 1 ClinicalOtsuka Pharmaceutical Co LtdMetabolic Dysfunction-Associated Steatotic Liver Disease
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
GolotimodSCV-07ApprovedVertaRussian FederationHepatitis C; Mucositisnull2009-01-01Head and Neck Neoplasms; Hepatitis C; Mucositis; Stomatitis
詳細
Caffeic AcidCABEApprovedThe University Of Texas MD Anderson Cancer Center, Moleculin LlcHemorrhage; Leukopenia; Thrombocytopenia
詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
共有：

採用情報法的規制サイトマッププライバシーポリシー利用規約
ウェブサイトに関するフィードバック
お問い合わせ

お問い合わせ
グローバル：+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8